Evidence for association of the G1733A polymorphism of the androgen receptor gene with recurrent spontaneous abortions

Fertility and Sterility

Volumn 90, Issue 5, 2008, Pages 2010.e9-2010.e12

  Karvela, Maria ^a   Stefanakis, Nikolaos ^a   Papadopoulou, Sophia ^a   Tsitilou, Sonia G ^a   Tsilivakos, Vasileios ^b   Lamnissou, Klea ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Locus Medicus Laboratory   (Greece)

Author keywords

androgen receptor; gene polymorphisms; Recurrent spontaneous abortions; risk factors

Indexed keywords

ADULT; ANDROGEN RECEPTOR GENE; ARTICLE; CASE CONTROL STUDY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; G1733A GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SPONTANEOUS ABORTION; WILD TYPE;

EID: 55149088849     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.04.071     Document Type: Article

References (42)

1. Wilcox A.J., Weinberg C.R., O'Connor J.F., Baird D.D., Schlatterer J.P., Canfield R.E., et al. Incidence of early loss of pregnancy. N Engl J Med 319 (1988) 189-194
2. Tempfer C., Unfried G., Zeillinger R., Hefler L., Nagele F., and Huber J.C. Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Hum Reprod 16 (2001) 1644-1647
3. Yoshimura T., Yoshimura M., Tabata A., Yasue H., and Okamura H. The missense Glu298Asp variant of the endothelial nitric oxide synthase gene is strongly associated with placental abruption. Hum Genet 108 (2001) 181-183
4. Hefler L.A., Tempfer C.B., Bashford M.T., Unfried G., Zeillinger R., Schneeberger C., et al. Polymorphisms of the angiotensinogen gene, the endothelial nitric oxide synthase gene, and the interleukin-1beta gene promoter in women with idiopathic recurrent miscarriage. Mol Hum Reprod 8 (2002) 95-100
5. Buchholz T., Lohse P., Kosian E., and Thaler C.J. Vasoconstrictively acting AT1R A1166C and NOS3 4/5 polymorphisms in recurrent spontaneous abortions (RSA). Am J Reprod Immunol 51 (2004) 323-328
6. Papazoglou D., Galazios G., Papatheodorou K., Liberis V., Papanas N., Maltezos E., et al. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil Steril 83 (2005) 959-963
7. Zammiti W., Mtiraoui N., Mercier E., Abboud N., Saidi S., Mahjoub T., et al. Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study. Thromb Haemost 95 (2006) 612-617
8. Karvela M, Papadopoulou S, Tsaliki E, Hatzaki A, Florentin-Arar L, Lamnissou K. Endothelial nitric oxide synthase gene polymorphisms in recurrent spontaneous abortions. Arch Gynecol Obstet. In press.
9. Quigley C.A., De Bellis A., Marschke K.B., el-Awady M.K., Wilson E.M., and French F.S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16 (1995) 271-321
10. Brown C.J., Goss S.J., Lubahn D.B., Joseph D.R., Wilson E.M., French F.S., et al. Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 44 (1989) 264-269
11. Chamberlain N.L., Driver E.D., and Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22 (1994) 3181-3186
12. Ding D., Xu L., Menon M., Reddy G.P., and Barrack E.R. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62 (2005) 133-139
13. Lu J., and Danielsen M. A Stu I polymorphism in the human androgen receptor gene (AR). Clin Genet 49 (1996) 323-324
14. Grad J.M., Lyons L.S., Robins D.M., and Burnstein K.L. The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer. Endocrinology 142 (2001) 1107-1116
15. Ross R.K., Pike M.C., Coetzee G.A., Reichardt J.K., Yu M.C., Feigelson H., et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 58 (1998) 4497-4504
16. Medeiros R., Vasconcelos A., Costa S., Pinto D., Morais A., Oliveira J., et al. Steroid hormone genotypes ARSTuI and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet 141 (2003) 91-96
17. Giovannucci E., Stampfer M.J., Krithivas K., Brown M., Dahl D., Brufsky A., et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A 94 (1997) 3320-3323
18. Kim JJ, Choung SH, Choi YM, Yoon SH, Kim SH, Moon SY. Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil Steril. In press.
19. Acromite M.T., Mantzoros C.S., Leach R.E., Hurwitz J., and Dorey L.G. Androgens in preeclampsia. Am J Obstet Gynecol 180 (1999) 60-63
20. Carlsen S.M., Romundstad P., and Jacobsen G. Early second-trimester maternal hyperandrogenemia and subsequent preeclampsia: a prospective study. Acta Obstet Gynecol Scand 84 (2005) 117-121
21. Saarela T., Jääskeläinen J., Tenhola S., Voutilainen R., and Heinonen S. Preeclampsia and androgen receptor gene CAG repeat length: results from both children and women. J Assist Reprod Genet 22 (2005) 269-275
22. Bachmann J., Feldmer M., Ganten U., Stock G., and Ganten D. Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 40 (1991) 511-515
23. Mantzoros C.S., Georgiadis E.I., Young R., Evagelopoulou C., Khoury S., Katsilambros N., et al. Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women. Am J Hypertens 8 (1995) 606-614
24. Gustafson D.R., Wen M.J., and Koppanati B.M. Androgen receptor gene repeats and indices of obesity in older adults. Int J Obes Relat Metab Disord 27 (2003) 75-81
25. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
26. Unfried G., Tempfer C., Schneeberger C., Widmar B., Nagele F., and Huber J.C. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 75 (2001) 683-687
27. Montgomery J.S., Price D.K., and Figg W.D. The androgen receptor gene and its influence on the development and progression of prostate cancer. J Pathol 195 (2001) 138-146
28. Giovannucci E., Stampfer M.J., Chan A., Krithivas K., Gann P.H., Hennekens C.H., et al. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians. Prostate 39 (1999) 130-134
29. Roberts R.O., Jacobson D.J., Rhodes T., Klee G.G., Leiber M.M., and Jacobsen S.J. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 61 (2004) 124-131
30. Ochsenkühn R., and De Kretser D.M. The contributions of deficient androgen action in spermatogenic disorders. Int J Androl 26 (2003) 195-201
31. Davis-Dao C.A., Tuazon E.D., Sokol R.Z., and Cortessis V.K. Male infertility and variation in CAG repeat length in the androgen receptor gene: a meta-analysis. J Clin Endocrinol Metab 92 (2007) 4319-4326
32. Terry K.L., De Vivo I., Titus-Ernstoff L., Shih M.C., and Cramer D.W. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res 65 (2005) 5974-5981
33. McGrath M., Lee I.M., Hankinson S.E., Kraft P., Hunter D.J., Buring J., et al. Androgen receptor polymorphisms and endometrial cancer risk. Int J Cancer 118 (2006) 1261-1268
34. Langdahl B.L., Stenkjaer L., Carstens M., Tofteng C.L., and Eriksen E.F. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Calcif Tissue Int 73 (2003) 237-243
35. Elhaji Y.A., Gottlieb B., Lumbroso R., Beitel L.K., Foulkes W.D., Pinsky L., et al. The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40. Breast Cancer Res Treat 70 (2001) 109-116
36. Giguère Y., Dewailly E., Brisson J., Ayotte P., Laflamme N., Demers A., et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 61 (2001) 5869-5874
37. Cox D.G., Blanché H., Pearce C.L., Calle E.E., Colditz G.A., Pike M.C., et al. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Res 8 (2006) R54
38. Weihua Z., Ekman J., Almkvist A., Saji S., Wang L., Gustafsson J.A., et al. Involvement of androgen receptor in 17beta-estradiol-induced cell proliferation in rat uterus. Biol Reprod 67 (2002) 616-623
39. Shiina H., Matsumoto T., Sato T., Igarashi K., Miyamoto J., Takemasa S., et al. Premature ovarian failure in androgen receptor-deficient mice. Proc Natl Acad Sci U S A 103 (2006) 224-229
40. Walters K.A., Allan C.M., Jimenez M., Lim P.R., Davey R.A., Zajac J.D., et al. Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility. Endocrinology 148 (2007) 3674-3684
41. Esteban E., Via M., González-Pérez E., Santamaría J., Dugoujon J.M., Vona G., et al. An unexpected wide population variation of the G1733A polymorphism of the androgen receptor gene: data on the Mediterranean region. Am J Hum Biol 17 (2005) 690-695
42. Ribeiro M.L., Santos A., Carvalho-Salles A.B., and Hackel C. Allelic frequencies of six polymorphic markers for risk of prostate cancer. Braz J Med Biol Res 35 (2002) 205-213